Search

UKISCRS 47th Annual Congress Preview

Check out the Eye News preview for UKISCRS' 47th Annual Congress in London, 1-3 November.

OSA Insights to Market win praise from members

OSA members praised the breadth of optical market insights provided by the Autumn meeting this week as a broad spectrum of suppliers gathered in London, reinforcing the strength of the trade body.

The Eyes Have It launches new report calling for a National Eye Care Plan for England to address surging patient demand

The Eyes Have It is a partnership of Macular Society, Fight for Sight / Vision Foundation, Royal National Institute of Blind People (RNIB), Association of Optometrists, The Royal College of Ophthalmologists and Roche Products Ltd.

The Worshipful Company Of Spectacle Makers closes 2023 with 9 new liverymen and 1 new court assistant

The Worshipful Company of Spectacle Makers brought a successful 2023 to a close with the admission of 9 new Liverymen at its December Court Lunch.

Don’t miss Optometry Tomorrow 2024

There is still time to register for the College of Optometrists’ flagship event, Optometry Tomorrow.

Age and gender impacts effectiveness of new gene therapy treatments for eye diseases, new study finds

Older women could be vulnerable to harmful inflammation from new gene therapies to treat incurable eye diseases, new research has found. The University of Bristol-led study, published in Molecular Therapy, reveal how age and gender affects inflammation caused by gene...

Conference Preview: OOC 2025

Leading us into July this year will be the 108th Oxford Ophthalmological Congress (OOC), the longest-standing congress dedicated to ophthalmology in the UK. This year, the OOC has attracted the largest number of abstracts it has ever seen in its...

Moorfields Eye Hospital, UCL Institute of Ophthalmology and Topcon Healthcare, Inc. launch Cascader Limited to advance AI-driven eyecare and Oculomics

Moorfields Eye Hospital NHS Foundation Trust, the UCL Institute of Ophthalmology (IoO), and Topcon Healthcare today announced the launch of Cascader Limited, a new medical technology company that aims to transform the detection and management of eye disease through artificial...

Treatment for cause of sudden sight loss now available through the NHS in England

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...